Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

Second patent update issued this month...


Two patent amendments issued in June. The latest one, 8,470,851, dated June 25th has been split off from 8,114,874 which was considered press-release worthy last February for protection of Ponatinib. The title of the new one distinguishes 'pyridine' from previous 'pyridazine'. Any chemists care to elaborate?

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=ariad.ASNM.&OS=AN/ariad&RS=AN/ariad

Of minor note, I was unaware Ariad sued USPTO for 400 day extension of '874 patent. These extensions are customary due to delays in patent office review. For example the '167 patent approved June 11th includes a 587 day extension (beyond the standard 14 year term).

http://news.priorsmart.com/ariad-pharmaceuticals-v-kappos-l6wK/